TY  - JOUR

T1  - Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent<i>SQSTM1</i>-mediated Paget’s disease of bone

JO  - BMJ Open

UR  - https://eprints.whiterose.ac.uk/151657/

PY  - 2019/09/04

AU  - Cronin O

AU  - Forsyth L

AU  - Goodman K

AU  - Lewis SC

AU  - Keerie C

AU  - Walker A

AU  - Porteous M

AU  - Cetnarskyj R

AU  - Ranganath LR

AU  - Selby PL

AU  - Hampson G et al

ED  - 

DO  - DOI: 10.1136/bmjopen-2019-030689

PB  - BMJ

VL  - 9

IS  - 9

SP  - e030689

EP  - e030689

Y2  - 2025/10/10

ER  -